Danaher (DHR) Stock Rising, Jefferies Drops Price Target

Jefferies dropped its price target on Danaher (DHR) stock this morning in light of its recent Fortive (FTV) split.
By Rachel Aldrich ,

NEW YORK (TheStreet) -- Shares of Danaher  (DHR) - Get Report  are up 0.71% to $80.91 this morning after Jefferies trimmed its price target on the stock to $92 from $105.

The firm has a "buy" rating on shares of the Washington, DC-based company.

Following the company's recent split from Fortive (FTV), a spin-off company of Danaher's test and measurement, industrial technologies and retail/commercial petroleum units, Jefferies provided guidance for a "new DHR."

The company is emerging as a "diversified healthcare-centric company," which the firm sees as opening it to an entirely new investor base, Jefferies said in an analyst note.

"We view DHR as one of the most attractive large cap ideas in our coverage universe," the firm added.

Separately, TheStreet Ratings rated this stock as a "buy" with a ratings score of A+.

The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, reasonable valuation levels and good cash flow from operations.

Although the company may harbor some minor weaknesses, TheStreet Ratings feels they are unlikely to have a significant impact on results.

You can view the full analysis from the report here: DHR

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

Loading ...